Abstract
Catalepsy is a pathological animal behavior that is usually associated with dysfunctions in the striatal pallidal system of the brain and can be caused by different reasons. It was previously demonstrated that hereditary catalepsy is linked to the 111.35–116.16 million bp fragment of chromosome 13 in mice. The level of mRNA content in 42 genes localized in this fragment was determined in the study. Two brain departments that are functionally associated with catalepsy (striatum and substantia nigra) were studied in mice from AKR line (resistant to catalepsy), cataleptic CBA line, and recombinant cataleptic AKR.CBA-D13Mit76 (D13) line. The latter was obtained by the transfer of indicated fragment of chromosome 13 from the CBA line to the genome of the AKR line. It was found that two genes (Ndufs4 and Ppap2a) in the striatum and ten genes (Esm1, Fst, Gm10735, Gm15322, Gm15323, Gm15324, Gm15325, Il6st, Il31ra, and Itga1) in the substantia nigra differ in the level of mRNA expression in AKR and D13 lines. The Mcidas gene mRNA level is lower in both structures in D13 line mice than in the AKR line. The expression of the Hspb3 and Mocs2 genes (that encode heat shock protein and molybdenum cofactor synthesis, respectively) is lower in the substantia nigra of CBA and D13 cataleptic line mice than in the AKR line resistant to catalepsy. These genes are considered to be the most likely candidate genes of the catalepsy. The coexpression of a large amount of genes in these brain structures in sick animals indicates the existence of a complex gene network that regulates hereditary catalepsy.
Similar content being viewed by others
Abbreviations
- Ddx4:
-
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4
- Esm1:
-
endothelial cell-specific molecule 1
- Fst:
-
follistatin
- Gpbp1:
-
GC-rich promoter binding protein 1
- Gzma:
-
granzyme a
- Hspb:
-
heat shock protein b
- Il6st:
-
interleukin 6 signal transducer
- Il31ra:
-
interleukin 31 receptor a
- Itga1:
-
integrin alpha 1
- Mcidas:
-
multiciliatic differentiation and DNA synthesis associated cell cycle protein
- Mocs2:
-
molybdenum cofactor synthesis 2
- Ndufs4:
-
NADH dehydrogenase (ubiquinone) Fe-S protein 4
- Polr2a:
-
polymerase (RNA) II polypeptide a
- Ppap2a:
-
phosphatic acid phosphatase type 2a
References
Esposito E., Di Matteo V., Di Giovann-i G. 2007. Death in the substantia nigra: A motor tragedy. Expert. Rev. Neurother. 7, 677–697.
Sanberg P.R., Bunsey M.D., Giordano M., Norman A.B. 1998. The catalepsy test: Its ups and downs. Behav. Neurosci. 102, 748–759.
Weder N.D., Muralee S., Penland H., Tampi R.R. 2008. Catotonia: A review. Ann. Clin. Psychiatry. 20, 97–107.
Daniels J. 2009. Catotonia: Clinical aspects and neurobiological correlates. J. Neuropsych. Clin. 21, 371–380.
Bazovkina D.V., Kulikov A.V., Kondaurova E.M., Popova N.K. 2005. Selection for the predisposition to catalepsy enhances depressive-like traits in mice. Russ. J. Genet. 41, 1002–1007.
Kulikov A.V., Tikhonova M.A., Lebedeva E.I., Chugui V.F., Popova N.K. 2005. Effects of experimental increases and decreases in thyroxine levels on the extent of cataleptic freezing reactions in rats. Neurosci. Behav Physiol. 35, 763–767.
Kulikov A.V., Popova N.K. 2008. Genetic control of catalepsy in mice. In: Genetic Predisposition to Disease. Eds. Torres S.L., Marin M.S. NY: Nova Science, pp. 215–236.
Ahlenius S., Hillegaart V. 1986. Involvement of extrapyramidal motor mechanisms in the supression of locomotor activity by antipsychotic drugs: A comparison between the effects produced by preand post-synaptic inhibition of dopaminergic neurotransmittion. Pharmacol. Biochem. Behav. 24, 1409–1415.
Klemm W.R. 1989. Drug effects on active immobility responses: What they tell us about neurotransmitter systems and motor functions. Prog. Neurobiol. 32, 403–422.
Wadenberg M.L. 1996. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci. Biobehav. Rev. 20, 325–339.
Caroff S.N., Mann S.C., Keck P.E., Jr., Francis A. 2000. Residual catatonic state following neuroleptic malignant syndrome. J. Clin. Psychopharm. 20, 257–259.
Paparrigopoulos T., Tzarellas E., Ferentinos P., Mourikis I., Liappas J. 2009. Catatonia as a risk factor for the develepment of neuroleptic malignal syndrome: Report of a case following treatment with clozapine. World J. Biol. Psychiatr. 10, 70–73.
Porsolt R.D., Moser P.C., Castagné V. 2010. Behavioral indices in antipsychotic drug discovery. J. Pharmacol. Exp. Ther. 333, 632–638.
De Ryck M., Teitelbaum P.1984. Morphine catalepsy as an adaptive reflex state in rats. Behav. Neurosci. 98, 243–361.
Zarrindast M.R., Bakhsha A., Rostami P., Shafagni B. 2002. Effects of intrahippocampal injection of GABAergic drugs on memory retention of passive avoidance learning in rats. J. Pharmacol. 16, 313–319.
Little P.J., Compton D.R., Mechoulam R., Martin B.R. 1989. Stereochemical effects of 11-hydroxy-dekta-8-THC-dimethylheptyl in mice and dogs. Pharmacol. Biochem. Behav. 32, 661–666.
Hauber W., Münkle M. 1997. Motor depressant effects mediated by dophamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen. Eur. J. Pharmacol. 323, 127–131.
Reavill C., Kettle A., Holland V., Riley G., Blackburn T.P. 1999. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist. Br. J. Pharmacol. 126, 572–574.
Koek W., Khanal M., France C.P. 2007. Synergic interactions between ‘club drugs’: gamma-hydroxybutyrate and phecyclidine enchance each other’s discriminative stimulus effect. Behavior Pharmacol. 18, 807–810.
Hartgraves S.L., Kelly P.H. 1984. Role of mesencephalic reticular formation in cholinergic-induced catalepsy and anticholinergic reversal of neuroleptic-induced catalepsy. Brain Res. 307, 47–54.
Kulikov A.V., Bazovkina D.V., Moisan M.P., Mormede P. 2003. The mapping of the gene susceptibility to catalepsy in mice using polymorphic microsatellite markers. Dokl. Biol. Sci. 393, 531–534.
Kulikov A.V., Bazovkina D.V., Kondaurova E.M., Popova N.K. 2008. Genetic structure of hereditary catalepsy in mice. Genes Brain Behav. 7, 506–512.
Kulikov A.V., Kozlachova E. Yu., Maslova G.V., Popova N.K. 1993. Inheritance of predisposition to catalepsy in mice. Behav Genet. 23, 379–384.
Chomczynski P., Sacchi N. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159.
Naumenko V.S., Kulikov A.V. 2006. Quantitative assay of 5-HT(1A) serotonin receptor gene expression in the brain. Mol. Biol. (Moscow). 40, 30–36.
Kulikov A.V., Naumenko V.S., Voronova I.P., Tikhonova M.A., Popova N.K. 2005. Quantitative RT-PCR of 5-HT1A and 5-HT2A serotonin receptor mRNAs using genomic DNA as an standard. J. Neurosci. Meth. 141, 97–101.
Kulikov A.V., Naumenko V.S. 2007. Problems of mRNA quantification in the brain Using RT-PCR. In: New Messenger RNA Research Communications. Ed. Kwang L.B. NY: Nova Science, pp. 53–68.
Naumenko V.S., Osipova D.V., Kostina E.V., Kulikov A.V. 2008. Utilization of a two-standard system in real-time PCR for quantification of gene expression in the brain. J. Neurosci. Meth. 17, 197–203.
Radoníc A., Thulke S., Mackay I.M., Landt O., Siegert W., Nitsche A. 2004. Guideline to reference gene selection for quantitative real-time PCR. Biochem. Biophys. Res. Commun. 313, 856–862.
Squire L.R., Berg D., Bloom F., du Lac S., Ghosh A. 2008. Fundamental Neuroscience. NY: Academic.
Stubbs J.L., Vladar E.K., Axelrod J.D., Kintner C. 2012. Multicilin promotes centriole assembly and ciliogenesis during multiciliate cell differentiation. Nature Cell Biol. 14, 140–147.
Pefani D.-E., Dimaki M., Spella M., Karantzelis N., Mitsiki E., Kyrousi C., Symeonidou I.-E., Perrakis A., Taraviras S., Lygerou Z. 2011. Idas, a novel phylogenetically conserved geminin-related protein, binds to geminin and is required for cell cycle progression. J. Biol. Chem. 286, 23234–23246.
Islam A., Deuster P.A., Devaney J.M., Ghimbovschi S., Chen Y. 2013. An exploration of heat tolerance in mice utilizing mRNA and microRNA expression analysis. PLoS ONE. 8, e72258–e72268.
Reiss J., Hahnewald R. 2011. Molybdenum cofactor deficiency: Mutations in GPHN, MOCS1, and MOCS2. Hum. Mutat. 32, 10–18.
Bazovkina D.V., Tibeikina M.A., Kulikov A.V., Popova N.K. 2011. Effects of lipopolysaccharide and interleukin-6 on cataleptic immobility and locomotor activity in mice. Neurosci. Lett. 487. 302-304.
Kondaurova E.M., Naumenko V.S., Sinyakova N.A., Kulikov A.V. 2011. Map3k1, Il6st, Gzmk, and Hspb3 gene coexpression network in the mechanism of freezing reaction in mice. J. Neurosci. Res. 89, 267–273.
Iancu O.D., Darakjian P., Malmanger B., Walter N.A., McWeeney S., Hitzemann R. 2011. Gene networks and haloperidol-induced catalepsy. Genes Brain Behav. 11, 29–37.
Iancu O.D., Oberbeck D., Darakjian P., Kawane S., Erk J., McWeeney S., Hitzemann R. 2013. Differential network analysis reveals genetic effects on catalepsy modules. PLoS ONE. 8, e58951–e58959.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N.A. Sinyakova, A.V. Kulikov, 2014, published in Molekulyarnaya Biologiya, 2014, Vol. 48, No. 5, pp. 733–741.
Rights and permissions
About this article
Cite this article
Sinyakova, N.A., Kulikov, A.V. Expression of genes in the 111.35–116.16 million bp fragment of chromosome 13 in brain of mice with different predisposition to hereditary catalepsy. Mol Biol 48, 638–645 (2014). https://doi.org/10.1134/S0026893314040141
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893314040141